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Summary
Objective: The fate of transplanted cells used in tissue engineering strategies should be followed. With this aim in view, the survival of
transplanted bone-marrow-derived mesenchymal cells within osteochondral defects was determined using transgenic rats to simulate
autologous transplantation.
Design: An autologous transplantation model was simulated using transgenic rats e whose transgenes produce no foreign proteins e as
donors, and wild-type rats as recipients. Dense masses of mesenchymal cells were prepared from the transgenic rats using the hanging-drop
culture technique. These cell masses were then transplanted into osteochondral defects created within the medial femoral condyle of wild-type
rats, wherein they are afﬁxed with ﬁbrin glue. The course of repair was assessed histologically. The survival of the transplanted cells was
ascertained by in situ hybridization of the transgenes.
Results: Twenty-four weeks after transplantation, the defects were repaired with hyaline-like cartilage, which was thicker than normal, and with
subchondral bone. Using the in situ hybridization technique, cells derived from the transplanted ones were detected within both the
cartilaginous and the subchondral bone layers.
Conclusion: Using this simulated autologous transplantation model, the survival of transplanted mesenchymal cells was monitored in vivo.
The ﬁndings indicate that the transplanted mesenchymal cells contributed to the repair of the osteochondral defects.
ª 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Cartilage
Repair
SocietyIntroduction
Although osteochondral defects repair spontaneously, the
tissue formed is of variable quality, ranging from a ﬁbrous
through a ﬁbrocartilaginous type to one of a hyaline-like
cartilaginous nature, depending on species and age as well
as on the location and the size of the defect1e3. However
the original hyaline cartilage is not regenerated. The tissue
degenerates gradually with time and osteoarthritis usually
ensues4e6. In order to facilitate the repair of defects, tissues
of various type, such as periosteal, perichondrial, or osteo-
chondral, have been transplanted7e10. Various cell types
also such as chondrocytes or mesenchymal cells, have
been applied, with resulting improvements in the hyaline-
like quality of the repair cartilage formed and in the clinical
symptoms11e18. However, true regeneration of the original
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Received 5 December 2003; revision accepted 27 June 2004.811hyaline cartilage layer still has not been achieved either
biochemically or biomechanically, and the ideal source of
cells for defect healing remains elusive.
In many trials, autologous transplantation has been
undertaken in that it avoids the problem of immunological
rejection by the host against the transplanted cells11,12,19.
However, it is difﬁcult to distinguish the autologously trans-
planted cells from host cells. Hence, it is still debated
whether the transplanted cells do actually survive and, if so,
whether they do indeed contribute to the formation of
the repair tissues. It is thus essential to follow the fate
of the autologously transplanted cells during the repair
process and to ascertain whether they themselves repopu-
late the defect or whether they merely stimulate the
host cells resident within the surrounding tissues to
enter it12.
Bone-marrow tissue contains mesenchymal stem cells
which are known to contribute to the regeneration of
mesenchymal tissues by differentiating into mesenchymal-
lineage progenitor cells, such as osteoblasts, chondro-
blasts, ﬁbroblasts, myoblasts or lipoblasts20,21. It has been
hypothesized that autologously transplanted mesenchymal
cells survive at the transplantation site and contribute to the
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and subchondral bone tissue.
In our previous publication, we reported on a simulated
autologous transplantation model involving transgenic rats
which could be used to monitor the fate of the autologously
transplanted cells. In this model, inbred female transgenic
rats serve as the cell donors and their wild-type counter-
parts as the recipients, transplantation being effected with-
out immunological rejection. Since the transgenes are
present homozygously within the transplanted cells, DNA
probes hybridize to both the relevant chromosomes using
the in situ hybridization technique. Hence, this model per-
mits a distinction between transplanted and host cells
in vivo, provided that the former survive22,23. The objective
of the present study was to follow the fate of transplanted
bone-marrow-derived mesenchymal cells during the repair
of osteochondral defects using this transgenic rat model.
Materials and methods
ANIMALS
Big Blue transgenic (Stratagene, La Jolla, CA) and
Fischer 344 wild-type female rats, aged 12 weeks and
weighing 200e250 g, were used in this study.
The Big Blue transgenic rat lineage is generated from the
Fischer 344 wild-type. Each of the cells of this transgenic rat
type contains 50e70 copies of a bacteriophage lambda
shuttle vector, which is homozygous for the bacterial pro-
moters lacI, alacZ, and Ampr. The lacI target gene encodes
the lac repressor protein, which binds to the lac operator
and blocks the transcription of the lacZ promoter gene.
Since the transcription of transgenes is theoretically sup-
pressed in mammals, they produce no foreign proteins from
these. Hence, transplantation between the transgenic and
the wild-type rat can be effected without immunological
rejection, and the model is thus considered to simulate
autologous transplantation24,25. All experimental proce-
dures employed in this study have been approved by the
Committee for Animal Research at the Kyoto Prefectural
University of Medicine, Japan.
CULTURING OF MESENCHYMAL CELLS
Transgenic female rats (nZ 4) were anesthetized by an
intraperitoneal injection of sodium pentobarbital (35 mg/kg
of body weight) and then killed. Bone-marrow cells were
removed bilaterally from the femora and tibiae under sterile
conditions and then suspended in phosphate-buffered
saline (PBS) containing 2% bovine serum albumin [(BSA)
Serologicals Proteins Inc., Kankakee, IL]. The cell suspen-
sions were then centrifuged (200! g for 5 min) to remove
serum components. The sedimented cells were treated with
sterile water for 10 s to disrupt the erythrocytes. They were
then resuspended in PBS containing 2% BSA and again
centrifuged (200! g for 5 min). The number of bone-
marrow cells was determined using a hemocytometer. Each
rat yielded approximately 3! 106 to 5! 106 cells, in-
cluding non-adhering ones and erythrocyte cells. The
cells were transferred to 100-mm-diameter culture dishes
(FALCON, Franklin Lakes, NJ) to which Dulbecco’s modi-
ﬁed Eagle medium [(DMEM) GIBCO, Grand Island, NY]
containing 10% fetal bovine serum [(FBS) ICN Biomedicals
Inc., Aurora, OH] and 0.06% kanamycin was added. The
cultures were incubated at 37(C in a humidiﬁed atmo-
sphere containing 5% CO2. The medium was ﬁrst changed
24 h after seeding and then every 3 days during the 10e14days of culturing in order to remove non-adhering cells. At
the end of the culture period, the growing ﬁbroblast-like
cells, which were considered to be of mesenchymal origin,
were 80% conﬂuent. The cells were detached from the
culture dishes by treatment with 0.05% trypsin and 0.02%
ethylenediaminetetraacetic acid (EDTA) for 5 min. They
were then counted in a hemocytometer.
GENERATION OF DENSE CELL MASSES
The mesenchymal cells were transferred to DMEM
containing 10% FBS and 0.06% kanamycin and maintained
in hanging-drop culture in a humidiﬁed atmosphere con-
taining 5% CO2 at 37(C for 60e72 h. Drops of cell
suspension were hung from the inside surface of the
culture dish covers. The cells gradually settled at the bottom
of the drop where they aggregated to form dense masses.
Each 40-ml drop initially contained 4! 103 cells. Approxi-
mately 24e28 cell masses, each about 0.6 mm in diameter,
were obtained from a single rat.
PREPARATION AND TREATMENT OF THE
OSTEOCHONDRAL DEFECTS IN WILD-TYPE RATS
Wild-type female rats (nZ 32) were anesthetized by an
intraperitoneal injection of sodium pentobarbital. An anterior
midline incision was made through the skin of the right knee
and the articular surface of the femur was then exposed
using a medial parapatellar retinacular approach. The knee
joint was immobilized in a deeply ﬂexed position, and
a cylindrical osteochondral defect, 1.5 mm in diameter and
3 mm in depth, was then created in the central weight-
bearing surface of the medial femoral condyle using a 22-
gauge needle. In the experimental group (nZ 16), four
separate masses of mesenchymal cells were introduced
into the defects and afﬁxed therein with ﬁbrin glue
(Beriplast, Aventis, Bridgewater, NJ). In the control group
(nZ 16), the defects were ﬁlled with ﬁbrin glue alone. All
rats were permitted free cage movement after surgery.
MACROSCOPIC AND HISTOLOGICAL EVALUATION
Four, 8, 12 and 24 weeks after surgery, the wild-type rats
were anesthetized with sodium pentobarbital, and then
perfused with physiological saline followed by 4% para-
formaldehyde (PFA) in 0.1 M phosphate buffer (PB). The
distal portions of the femora were removed and immersed in
the same ﬁxative solution (4% PFA in 0.1 M PB) for 24 h at
4(C. They were then decalciﬁed in 0.5 M EDTA ( pH 7.5) for
2 weeks at ambient temperature, this procedure being
followed by gradient replacement with 20% sucrose for 24 h
at 4(C. The femora were then rapidly frozen and
cryosectioned in a cryostat (CM3050 S, Leica, Nussloch,
Germany). The 14-mm-thick sections were stained either
with 0.01% safranin O or with 0.05% toluidine blue in
preparation for light microscopy. The following features
were assessed: surface regularity, thickness of the cartilage
layer, repair of the subchondral bone layer, matrix-staining
of the cartilaginous and bony compartments, and integra-
tion of the repair tissue with the surrounding host tissues.
The extent of the inﬂammatory response and osteophyte
formation were also evaluated.
IN SITU HYBRIDIZATION
Transgenes within the transplanted cells were detected at
the 24-week juncture by in situ hybridization, which was
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probe was prepared by Nick translation using digoxigenin-
11-dUTP (Roche, Mannheim, Germany). The transgene of
a Big Blue transgenic rat (Lambda shuttle vector, Stra-
tagene) served as a template. Cryosections were ﬁxed in
4% PFA for 15 min at ambient temperature, digested with
0.8% pepsin in 0.2 M HCl for 15 min at 37(C and then again
ﬁxed in PFA for 15 min, after which they were dehydrated in
ethanol at ambient temperature. Chromosomal DNA was
denatured by treating the sections ﬁrst with 70% formamide
in double-strength sodium saline citrate for 5 min at 70(C,
then with ice-cold 70% ethanol for 5 min and ﬁnally with
100% ethanol for a similar period. The denatured DNA
probe was transferred to the sections and the hybridization
then carried out overnight at 37(C. The sections were
incubated with alkaline-phosphatase-conjugated anti-digox-
igenin antibody Fab-fragments (Roche, Mannheim, Ger-
many) for 30 min, and the reaction product was then
visualized by treatment with 4-nitro blue tetrazolium
chloride/5-bromo-4-chloro-3-indolyl phosphate p-toluidine
salt for 8e12 h. The sections were then evaluated micro-
scopically.
Results
MACROSCOPIC OBSERVATIONS
In neither the experimental nor the control group of rats
were signs of infection, immunological rejection, osteophyte
formation or osteoarthritis apparent in the knees at any time
after surgery (4, 8, 12 or 24 weeks). In the control group
(ﬁbrin glue alone), the defect margins were clearly recog-
nizable at 4, 8, 12 and 24 weeks. At 4 weeks, the defect
surfaces were slightly depressed and covered with a shiny,
semi-transparent tissue. After 24 weeks, the defect surfa-
ces were still slightly depressed and more irregular than at 4
weeks [Fig. 1(AeD)]. In the experimental group (trans-
planted mesenchymal cells and ﬁbrin glue), the margins of
the defects were likewise recognizable 4 weeks after
surgery. Similarly, their surfaces were slightly depressed
and covered with a shiny, semi-transparent tissue. At 8 and
12 weeks, the margins of the defects were still recognizable
but their surfaces, though irregular, were not depressed. At
24 weeks, the margins of the defects were still discernible
but not sharply deﬁned. Their surfaces were smooth and
evinced no obvious signs of degeneration [Fig. 2(AeD)].
HISTOLOGICAL OBSERVATIONS
In the control group, the margins of the defects were
clearly recognizable and their surfaces were slightly irregular
4 weeks after surgery. They were ﬁlled with ﬁbrous tissue,
which failed to stain with either safranin O or toluidine blue.
No osseous tissue was observed within the bony portion of
the defects [Fig. 3(A)]. Likewise at 8 and 12 weeks, the
margins of the defects were clearly recognizable and their
surfaces were slightly irregular. They were still ﬁlled with
ﬁbrous tissue. Neither cartilage nor bone was observed
within the respective compartments [Fig. 3(B, C)]. At 24
weeks, isolated patches of cartilage tissue, which were
stained faintly with safranin O, were apparent, but most of
the defect area was still ﬁlled with ﬁbrous tissue [Fig. 3(D)].
In the experimental group, the margins of the defects
were clearly recognizable 4 weeks after surgery and their
surfaces were slightly irregular. They were ﬁlled with ﬁbrous
tissue, which was well integrated with the surrounding bone
in the deeper regions. The tissue stained intensely withsafranin O and metachromatically with toluidine blue, indi-
cating the presence of a cartilaginous matrix. Numerous
cells within the repair tissue were surrounded by a lacuna
and they were thus deduced to be chondrocytes. However,
they were isotropically organized. The repair cartilage was
thicker than the normal cartilage layer [Fig. 4(A)].
At 8 weeks, the margins of the defects were still recog-
nizable and their surfaces were slightly irregular. The repair
cartilage was still thicker than the normal cartilage layer.
The bony compartment contained mostly ﬁbrous tissue,
although some new bone had been laid down in the deeper
regions [Fig. 4(B)].
At 12 weeks, the margins of the defects were still recog-
nizable and their surfaces were less irregular than at 8
weeks [Fig. 4(C)]. By 24 weeks, the defect surfaces were
smooth and no longer depressed. At both 12 and 24 weeks,
the matrix of the repair cartilage stained positively with
safranin O staining, but, as at 8 weeks, the chondrocytes
were isotropically arranged. By 24 weeks, the thickness of
the repair cartilage had decreased slightly but the height of
the normal cartilage layer had not been attained. In deeper
regions of the bony compartment, the osseous tissue was
well remodeled and well integrated with host bone
[Fig. 4(D)].
IN SITU HYBRIDIZATION
For the in situ hybridization, sections of wild-type rat
femora served as negative controls and those of transgenic
ones as positive controls. Since all cells of the transgenic
rats are homozygous for the transgenes, the DNA probes
Fig. 1. Macroscopic views of the control group of knees 4 weeks
(A), 8 weeks (B), 12 weeks (C), and 24 weeks (D) after surgery.
Bar: 1 mm.
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weeks (A), 8 weeks (B), 12 weeks (C), and 24 weeks (D) after
surgery. Bar: 1 mm.hybridize to both of the relevant chromosomes. Hence,
each cell exhibits a double signal.
Positive cells were detected within the cartilage, sub-
chondral bone, and bone marrow of transgenic rats
(positive control), but not within the corresponding tissues
of the wild-type ones [(negative control) Fig. 5(AeD)]. In the
experimental group of rats, positive cells were observed
within both the cartilaginous [Fig. 5(E)] and the bony
[Fig. 5(F)] compartments of the defects 24 weeks after
transplantation. This ﬁnding indicates that the repair tissues
contained cells that were derived from the transplanted
ones. To assess the proportion of positive cells in each type
of repair tissue, the numbers were counted in randomly
selected areas (0.14 mm! 0.21 mm) at a magniﬁcation of
!160 in the light microscope. Approximately 30e40% of
cells in the cartilaginous layer and about 10e20% of those
in the subchondral bone layer, at a maximum, registered
positive.
Discussion
In this study, mesenchymal cells derived from the bone
marrow of transgenic rats were transplanted into osteo-
chondral defects created in their wild-type counterparts.
Twenty-four weeks after surgery, the cartilaginous com-
partment of the defects was ﬁlled with a hyaline-like type of
repair cartilage and the bony portion with osseous tissue.
Each layer contained cells that were derived from the
transplanted mesenchymal population.
Several tools, such as radioisotopes, gene markers and
cell-surface antigens, have hitherto been employed to follow
the fate of autologously transplanted cells. However, their
use may be associated with one of several disadvantages,Fig. 3. Photomicrographs of tissue sections (stained with safranin O) through the control group of defects 4 weeks (A), 8 weeks (B), 12 weeks
(C), and 24 weeks (D) after surgery. Bar: 0.2 mm.
815Osteoarthritis and Cartilage Vol. 12, No. 10Fig. 4. Photomicrographs of tissue sections (stained with safranin O) through the experimental group of defects 4 weeks (A), 8 weeks (B),
12 weeks (C), and 24 weeks (D) after surgery. Bar: 0.2 mm.
Fig. 5. Photomicrographs illustrating in situ hybridization. The articular cartilage, subchondral bone and bone-marrow cells of wild-type (A, C)
and transgenic (B, D) rats served as negative and positive controls, respectively. In the experimental group of rats, the cartilage (E) and
subchondral bone layers (F) of the repaired defects contained cells with a double signal 24 weeks after surgery. The insets represent higher
magniﬁcation views of the boxed examples. Bars: 20 mm (AeD and in the insets in E and F) and 10 mm (E, F).
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logical rejection or selective marking26e30. The transgenic
rat method used in the present study circumvents these
difﬁculties.
The mesenchymal cell masses used for transplantation
were prepared by the hanging-drop culture technique,
which was originally developed for the three-dimensional
culturing of thymus cells31. By this means, cell agglomer-
ations of high density can be obtained. The concentration
process does not have an obviously adverse inﬂuence on
the mesenchymal cells, since more than 90% of the
population survived it according to the trypan-blue exclusion
test.
Fibrin glue was used to afﬁx the cell masses within the
defects. The material acts instantaneously, thereby
preventing cell loss32,33, and elicits no immunological
response. Fibrin glue alone (control group) was not capable
of inducing compartment-speciﬁc repair of the osteochondral
defects.
The potential of bone-marrow-derived mesenchymal cells
to form cartilage and bone is well known14,20,21,34,35. An
additional advantage of using bone-marrow cells in a clinical
context is that they are obtainable by minimally invasive
means.
Using our simulated autologous transplantation model in
conjunction with in situ hybridization, we ascertained that
the transplanted mesenchymal cells contributed to the cell
populations in the repair tissues, albeit to different degrees:
30e40% in the cartilaginous compartment and 10e20% in
the bony one, at a maximum. Hence, transplanted mesen-
chymal cells are capable of facilitating the compartment-
speciﬁc repair of osteochondral defects. However, the
repair result achieved is not ideal. Further studies, involving
perhaps growth factors and gene therapy, must now be
undertaken to optimize regeneration of the original hyaline
cartilage layer36,37. Notwithstanding, our ﬁnding that trans-
planted mesenchymal cells contribute a part of the repair
tissues is an important one. This information may help us to
fathom the role played by these cells in the healing of
osteochondral defects.
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